Arxis, Inc. (NASDAQ:ARXS) Stock Has Consensus Target Price of $55.36 According to Analysts

Key Points

• Analysts remain broadly bullish: Arxis has a “Moderate Buy” consensus from 13 brokerages, with 11 buy ratings and two holds. The average 12-month price target is $55.36, while several firms recently raised targets into the $63–$67 range.
• Business outlook has strengthened: Arxis raised its 2026 revenue guidance to $2.1 billion, above the roughly $2.0 billion consensus, while also increasing earnings guidance and providing a 2027 outlook.
• Valuation remains a key risk: The stock was recently trading at $50.82 with a reported P/E ratio of 635.25, making it particularly sensitive to changes in growth expectations and investor risk appetite.

Shares of Arxis, Inc. (NASDAQ:ARXS - Get Free Report) have been given a consensus rating of "Moderate Buy" by the thirteen brokerages that are currently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a hold recommendation and eleven have assigned a buy recommendation to the company. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $55.36.

Several equities analysts have recently weighed in on ARXS shares. Royal Bank Of Canada raised their price target on Arxis from $60.00 to $64.00 and gave the company an "outperform" rating in a report on Friday. Morgan Stanley raised their target price on Arxis from $62.00 to $66.00 and gave the company an "overweight" rating in a research report on Friday. Jefferies Financial Group reissued a "buy" rating and issued a $60.00 price objective on shares of Arxis in a research report on Sunday, August 2nd. Wells Fargo & Company boosted their price objective on shares of Arxis from $52.00 to $63.00 and gave the stock an "overweight" rating in a research report on Tuesday, August 4th. Finally, Citigroup raised their price objective on Arxis from $61.00 to $67.00 and gave the company a "buy" rating in a research note on Thursday, August 13th.

Hedge Funds Weigh In On Arxis

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Squarepoint Ops LLC bought a new stake in shares of Arxis in the 2nd quarter valued at $19,506,000. Alyeska Investment Group L.P. bought a new position in Arxis during the 2nd quarter valued at approximately $13,842,000. State Street Corp bought a new stake in shares of Arxis in the second quarter worth $9,948,000. BlueCrest Capital Management Ltd bought a new stake in Arxis during the second quarter valued at about $7,389,000. Finally, Grandeur Peak Global Advisors LLC bought a new position in Arxis during the second quarter valued at $2,740,000.

Arxis Price Performance

Shares of ARXS stock opened at $50.82 on Monday. The company has a current ratio of 4.70, a quick ratio of 3.27 and a debt-to-equity ratio of 0.32. The stock's 50 day moving average is $51.25. Arxis has a 52 week low of $33.15 and a 52 week high of $61.50. The firm has a market cap of $21.89 billion and a P/E ratio of 635.25.

Key Headlines Impacting Arxis

Here are the key news stories impacting Arxis this week:

• Positive Sentiment: Arxis raised its full-year 2026 revenue guidance to $2.1 billion, above the roughly $2.0 billion analyst consensus. The company also increased its earnings guidance and provided an outlook for 2027, signaling continued operating momentum. Arxis Raises Earnings Guidance for the Full Year 2026
• Positive Sentiment: Third-quarter revenue increased, while management’s earnings commentary and the raised 2026 outlook reinforced expectations for growth. The results and outlook were discussed during the company’s earnings call. Arxis Q3 Revenue Rises; 2026 Guidance Raised, 2027 Outlook Issued
• Positive Sentiment: Morgan Stanley raised its Arxis price target from $62 to $66 and maintained an overweight rating. RBC likewise increased its target from $60 to $64 while retaining an outperform rating. The revisions imply substantial upside from the referenced $50.82 share price and indicate improving analyst confidence. RBC Raises Price Target on Arxis
• Neutral Sentiment: Despite the positive fundamental and analyst news, Arxis trades at a very high reported price-to-earnings ratio, leaving the stock sensitive to changes in growth expectations and investor risk appetite.

Arxis Company Profile

We are a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical components engineered for cutting-edge performance in extreme environments. Leveraging significant intellectual property (“IP”) and world-class engineering capabilities, we design and deliver innovative solutions that address some of our customers' most complex performance needs. Arxis is the result of a deliberate and disciplined strategy executed by our sponsor, Arcline, and the Arxis management team to create a purpose-built, cohesive business through targeted acquisitions with similar product and end market characteristics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.